China’s Qihan Biotech nets $67m funding from LAV, Sequoia, others

China’s Qihan Biotech nets $67m funding from LAV, Sequoia, others

Gene technology-focused Qihan Biotech on Monday said it has bagged as much as $67 million in its Series A++ round from a slew of investors.